東瑞製葯：2022中期報告.pdf

1、01Contents目錄INTERIM REPORT 2022 二零二二年中期報告Corporate Information2公司資料Group Structure4本集團架構圖Chairmans Statement5主席報告Management Discussion and Analysis10管理層討論及分析Other Information21其他資料Condensed Consolidated Statement of Profit or Loss29簡明綜合損益表Condensed Consolidated Statement of Comprehensive Income30簡明綜

2、合全面收益表Condensed Consolidated Statement of Financial Position31簡明綜合財務狀況表Condensed Consolidated Statement of Changes in Equity33簡明綜合權益變動表Condensed Consolidated Statement of Cash Flows35簡明綜合現金流量表Notes to the Interim Financial Information39中期財務資料附註DAWNRAYS PHARMACEUTICAL(HOLDINGS)LIMITED 東瑞製葯（控股）有限公司02C

3、orporate Information公司資料董事會執行董事李其玲女士（主席）熊融禮先生陳紹軍先生（於二零二二年二月十六日辭任）非執行董事梁康民先生獨立非執行董事勞同聲先生EDE,Ronald Hao Xi先生林明儀女士總裁陳紹軍先生（於二零二二年二月十六日辭任）吳偉賢先生（於二零二二年二月十六日被委任）審核委員會勞同聲先生（主席）EDE,Ronald Hao Xi先生林明儀女士薪酬委員會EDE,Ronald Hao Xi先生（主席）李其玲女士勞同聲先生林明儀女士提名委員會李其玲女士（主席）勞同聲先生EDE,Ronald Hao Xi先生林明儀女士核數師安永會計師事務所執業會計師註冊公眾利益

4、實體核數師BOARD OF DIRECTORSEXECUTIVE DIRECTORSMs.LI Kei Ling(Chairman)Mr.HUNG Yung LaiMr.CHEN Shaojun(resigned on 16 February 2022)NON-EXECUTIVE DIRECTORMr.LEUNG Hong ManINDEPENDENT NON-EXECUTIVE DIRECTORSMr.LO Tung Sing Tony Mr.EDE,Ronald Hao Xi Ms.LAM Ming Yee JoanCHIEF EXECUTIVE OFFICERMr.CHEN Shaoju

5、n(resigned on 16 February 2022)Mr.WU Weixian(appointed on 16 February 2022)AUDIT COMMITTEEMr.LO Tung Sing Tony(Chairman)Mr.EDE,Ronald Hao Xi Ms.LAM Ming Yee JoanREMUNERATION COMMITTEEMr.EDE,Ronald Hao Xi(Chairman)Ms.LI Kei LingMr.LO Tung Sing Tony Ms.LAM Ming Yee JoanNOMINATION COMMITTEEMs.LI Kei Li

6、ng(Chairman)Mr.LO Tung Sing Tony Mr.EDE,Ronald Hao Xi Ms.LAM Ming Yee JoanAUDITORSErnst&YoungCertified Public Accountants Registered Public Interest Entity Auditor03Corporate Information公司資料INTERIM REPORT 2022 二零二二年中期報告主要往來銀行中國銀行（香港）有限公司，香港香港上海滙豐銀行有限公司，香港中國工商銀行蘇州市吳中支行中國農業銀行蘇州市南門支行中國銀行蘇州市吳中支行總辦事處及主要營